Literature DB >> 2143722

Treatment failure with teicoplanin and response to oral antibiotic regimens.

P H McWhinney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2143722     DOI： 10.1007/bf01979479

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  7 in total

1.  Clinical efficacy of teicoplanin.

Authors:  P Calain; F Waldvogel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

2.  Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.

Authors:  R J Dworkin; B L Lee; M A Sande; H F Chambers
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

3.  Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.

Authors:  N Galanakis; H Giamarellou; N Vlachogiannis; C Dendrinos; G K Daikos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.

Authors:  P Lewis; J J Garaud; F Parenti
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

5.  Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients.

Authors:  C Leport; C Perronne; P Massip; P Canton; P Leclercq; E Bernard; P Lutun; J J Garaud; J L Vilde
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

6.  Teicoplanin in the treatment of gram-positive-bacterial endocarditis.

Authors:  P Martino; M Venditti; A Micozzi; C Brandimarte; G Gentile; C Santini; P Serra
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

7.  Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.

Authors:  P Calain; K H Krause; P Vaudaux; R Auckenthaler; D Lew; F Waldvogel; B Hirschel
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.